Related Experiment Videos
Deep Venous Thrombosis: Early Discharge Strategies and Outpatient Management
1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Journal of Thrombosis and Thrombolysis
|January 1, 1997
Summary
Low-molecular-weight heparins (LMWHs) offer safe and effective deep venous thrombosis (DVT) treatment, enabling shorter hospital stays or outpatient management. Further long-term studies are needed for optimal use.
Area of Science:
- Cardiology
- Hematology
- Pharmacology
Background:
- Conventional deep venous thrombosis (DVT) management involves prolonged hospitalization with unfractionated heparin (UFH) and warfarin.
- Low-molecular-weight heparins (LMWHs) present an alternative with improved bioavailability, dosing, and safety profiles.
Purpose of the Study:
- To evaluate the efficacy and safety of LMWHs in DVT management.
- To propose a triage system for outpatient or short-term hospitalization management of DVT patients using LMWHs.
Main Methods:
- Review of existing literature on LMWH and UFH in DVT treatment.
- Development of management algorithms for different patient triage pathways.
Main Results:
- LMWHs demonstrate comparable efficacy and safety to UFH for DVT treatment.
- LMWHs facilitate reduced hospitalization durations and potential for outpatient management.
Conclusions:
- LMWHs represent a viable option for initial DVT management, allowing for outpatient or short-term hospital care.
- A structured triage system can optimize LMWH use in DVT patients.
- Longer-term data will further refine the optimal use and safety of LMWHs.